Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	145.31	54.94	61.74	207.34	191.92
Short-Term Investments	33.8	112.95	151.68	-	-
Cash & Short-Term Investments	179.1	167.89	213.42	207.34	191.92
Cash Growth	6.68%	-21.33%	2.93%	8.03%	-6.45%
Accounts Receivable	54.7	54.82	46.16	27.62	29.98
Inventory	64.9	55.72	56.76	42.33	27.31
Other Current Assets	0.76	-	-	0.21	0.23
Total Current Assets	299.47	278.44	316.34	277.5	249.44
Net Property, Plant & Equipment	23.97	24.13	33.47	39.15	33.17
Other Intangible Assets	135.54	61.04	71.27	75.12	83.83
Long-Term Investments	8.65	4.23	10.4	9.73	8.65
Other Long-Term Assets	32.34	32.14	31.38	24.3	22.22
Total Assets	499.96	399.99	462.85	425.8	397.32
Accounts Payable	105.9	66.61	72.53	54.47	42.47
Current Portion of Long-Term Debt	5.34	4.25	1.82	1.77	1.88
Current Portion of Leases	3.37	2.95	3.62	3.47	2.42
Other Current Liabilities	1.19	-	-	-	-
Total Current Liabilities	115.79	73.8	77.97	59.7	46.77
Long-Term Debt	92.72	78.15	136.6	131.62	139.01
Long-Term Leases	14.35	26.97	29.51	29.84	18.46
Other Long-Term Liabilities	-	-	-	-	0.17
Total Long-Term Liabilities	107.07	105.12	166.11	161.46	157.63
Total Liabilities	222.86	178.92	244.07	221.16	204.4
Common Stock	8.01	7.77	7.67	7.51	7.43
Additional Paid-in Capital	513.26	488.99	478.43	462.3	455.25
Accumulated Other Comprehensive Income	28.82	-0.21	-2.06	-8.74	3.4
Retained Earnings	-272.98	-275.49	-265.26	-256.43	-273.17
Shareholders' Equity	277.1	221.06	218.78	204.64	192.92
Total Liabilities & Equity	499.96	399.99	462.85	425.8	397.32
Total Debt	115.78	112.31	171.55	166.69	161.76
Net Cash (Debt)	63.33	55.58	41.88	40.65	30.16
Net Cash Growth	13.94%	32.72%	3.03%	34.76%	-30.18%
Net Cash Per Share	-	0.71	0.58	0.57	0.43
Book Value	277.1	221.06	218.78	204.64	192.92
Book Value Per Share	-	2.81	3.02	2.89	2.75
Tangible Book Value	141.56	160.02	147.51	129.52	109.08
Tangible Book Value Per Share	-	2.04	2.03	1.83	1.56

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q